Novel Biomarkers of Gastrointestinal Cancer

Novel Biomarkers of Gastrointestinal Cancer

Gastrointestinal (GI) cancer is a major cause of morbidity and mortality in the world. Since early diagnosis and optimal treatment selection are crucial to improving the prognosis of these diseases, the discovery of useful biomarkers has the potential to greatly reduce their burden. Recent technical...

Full description

Bibliographic Details
Format: eBook
Language:English
Published: Basel MDPI - Multidisciplinary Digital Publishing Institute 2022
Subjects:
Oncology
16S rRNA amplicon
advanced adenoma
advanced gastric cancer
AFP
artificial intelligence
biomarker
biomarkers
cancer screening
cancer screening tests
chemoresistance
circulating tumour cell (CTC)
cirrhosis
colorectal cancer
colorectal neoplasms
CXCR4
early detection of cancer
epigenetic regulation genes
extracellular vesicles
gastric cancer
GSVA
hepatocellular cancer
hepatocellular carcinoma
liquid biopsy
liver fibrosis
long non-coding RNA
machine learning
MALDI-TOF
metagenomics
microbiome
microRNA
miR-129-1-3p
miR-566
molecular genetic markers
mouse model
mRNA
n/a
neoadjuvant chemoradiation
oesophageal cancer
overall survival
plasminogen activator inhibitor type 1 (PAI-1)
precision medicine
prognosis
proteomics
rectal cancer
recurrence
screening
serine proteases
serpins
SHG/TPEF microscopy
somatic mutations
stool
targeted therapy
tumour microenvironment
unfolded protein
unfolded protein score
urinary miRNA
urokinase plasminogen activator (uPA)
urokinase plasminogen activator receptor (uPAR)
Online Access:Open Access: DOAB: description of the publication
Open Access: DOAB, download the publication

Internet

Open Access: DOAB: description of the publication
Open Access: DOAB, download the publication

Similar Items